| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10486215 | Value in Health | 2015 | 11 Pages | 
Abstract
												In concordance with current asthma management guidelines, inhaled LABAs should not be prescribed as monotherapy to patients with asthma. The findings suggest the presence of time-dependent confounding by asthma severity, which was accounted for by the marginal structural model.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Medicine and Dentistry (General)
												
											Authors
												Ayad K. MSPharm, RPh, PhD, MACE, Abraham G. PharmD, MSPH, PhD, FISPE, Almut G. RPh, PhD, FISPE, Richard PhD, Xiaomin PhD, Leslie PharmD, 
											